RESISTANCE TO ANTIBIOTICS IN BELGIUM. AMR Policy Dialogue November 22, 2018
|
|
- Berniece Sutton
- 5 years ago
- Views:
Transcription
1 RESISTANCE TO ANTIBIOTICS IN BELGIUM AMR Policy Dialogue November 22, 2018 Boudewijn Catry Service Healthcare-associated infections and antimicrobial resistance
2 Point prevalence survey: PPS (photo) Surveillance continue (film) &
3 Conclusion on Pictures Healthcare associated infections (HAI) prevalence (%) in Belgium Hospitals: 7.3 (2017) Long term care facilities (LTCFs): 3.5 (2016) Estimated number of patients per year with an HAI in Belgium Hospital: LTCFs: Disability adjusted lifye years (DALY) calculations: Throughout Europe, this study concluded that an estimated number of casualties are annually attributed to antimicrobial resistance. For Belgium, this number has been estimated at 530 deaths annually. Among these, 240 and 70 could be attributed to third-generation cephalosporin resistant Escherichia coli and Klebsiella pneumoniae (excluding those resistant to colistin and/or carbapenem), respectively, and 133 to MRSA (methicillin resistant Staphylococcus aureus). Further actions should focus on a reduction of inappropriate antimicrobial consumption and adequate preventive measures including hand hygiene and other infection control policies. Latour Katrien & Eline Vandael Brecht Devleeschauwer
4 Surveillances Gram - MRSA FEEDBACK C. difficile & Campaigns BeH-SAC Blood stream infections ICU & SSI VRE Indicators Rectangle = mandatory
5 CB1 CB2 MULTIDRUG RESISTANT ORGANISMS Microorganism Resistance MRSA Staphylococcus aureus Met(h)icillin ESBL+ Enterobacteriaceae 3 de generation cephalosporins (E.coli / Klebsiella / ) CPE Enterobacteriaceae Carbapenems VRE Enterococcus faecalis/faecium Vancomycin MDR Pseudomonas/Acinetobacter Different classes CDIF Clostridium difficile Intrinsic (Anaërobic) Urgent inquiries* e.g. Candida auris, Mycobacterium chimaera Intrinsic antibacterial, and/or multi antifungal resistance *ECDC Latour Katrien
6 Slide 5 CB1 Catry, Boudewijn; 29/06/18 CB2 Catry, Boudewijn; 29/06/18
7 Skin (MRSA) versus Gut bacteria (ESBL, CPE), Belgium Incidence of MRSA and ESBL+ and CPE+ E. coli & K. pneumoniae per 1000 admissions (Belgian acute care hospitals; clinical samples only) ESBL+ and CPE+ E. coli et K. pneumoniae /1000 admissions ESBL+ Escherichia coli ESBL+ Klebsiella pneumoniae #REF! CPE+ Klebsiella pneumoniae MRSA Timely feedback is needed, also for outbreak support team (OST) Katrien Latour & Béatrice Jans MRSA: methicillin resistant Staphylococcus aureus; ESBL: extended spectrum beta-lactamase CPE: carbapenemase producing
8 EARS-net Belgium, S. aureus, E. coli, E. faecium blood, evolution of multiple resistance, Mertens, K in press
9 EARS-net Belgium, E. coli (Urine vs Blood) Mertens, K in press
10 Remarkable findings 2017 Earsnet-Belgium Blood/CSF* *Preliminary results validation by NRC s ongoing S. aureus: decline MRSA: 8.7%IR in 2017 (versus 12.2%IR in 2016) E. coli: no increase in multi-resistance K. pneumoniae: no further increase R% for 3GC and carbapenems E. faecium: rise in resistance% vancomycin (5.5%R versus 1.7%R in 2016), teicoplanine (6.5%R versus 1.2%R in 2016) and linezolid (2.4%R versus 0.5%R in 2016) Thomas Struyf Karl Mertens
11 Surveillances Gram - MRSA FEEDBACK C. difficile & Campaigns BeH-SAC Blood stream infections ICU & SSI VRE Indicators Rectangle = mandatory
12 Clostridium difficile mean incidence per 1000 admissions (BE ) Incidence moyenne des infections à C. difficile (ICD) dans les hôpitaux aigus, [Belgique ] N/1000 admissions ICD associés à l'hopital Total des ICD NOTE: - ICD associées à l hôpital: début des symptômes 2 jours après l admission - Calcul de l incidence: Inclusion de tous les hôpitaux ayant fourni des données complètes (numérateurs et dénominateurs) au moins 1 semestre/an Mortgat ea., in press
13 Clostridium difficile (CDIF), stratified by province (BE, 2017) Incidence moyenne des infections à C. difficiles (ICD) dans les hôpitaux aigus, par province [N/ journées d hospitalisation, Belgique 2017] Mortgat ea., in press Note: Incidence moyenne de tous les hôpitaux aigus ayant participé à au moins 1 semestre. Les chiffres pour chaque province indiquent le nombre d hôpitaux-semestres. Les catégories (couleurs) pour l incidence sont basées sur les quartiles de la distribution.
14 Relationship Infuenza like illnes antimicrobial consumption - CDIF Figuur 1Non-pediatric antimicrobial use in the community in Daily Defined Doses per 1000 inhabitant days. Belgium Bruyndonckx et al., submitted
15 Surveillance & notification Outbreak SCIENSANO Reference lab Outbreak support Competent authorities experts Elisabeth Miller & Hélène De Pauw
16 Enkele gegevens Enterobacteriaceae Enterobacteriaceae Enterobacteriaceae Enterobacteriaceae Miller E, De Pauw H
17 Compliance hand hygiene De Pauw H, Benhammadi N, et al. 2018
18 Compliance stratified by indication De Pauw H, Benhammadi N, et al. 2018
19 Compliance HH before sterile or invasive contact De Pauw H, Benhammadi N, et al. 2018
20 Compliance Hand hygiene in ICU BE (Fonguh et al. Archives Public Health 2016)
21 Ventilator associated pneumonia, ICU BE Pneumonien per 1000 patient/intubatie dagen IZ verworven Intubatie geassocieerd Intubatie gebruik Intubatie dagen /1000 patient dagen Mertens K, WIV-ISP Jaar Figuur 2: Evolutie van IZ-verworven en intubatie geassocieerde pneumoniën, en intubatie gebruik op Intensieve Zorgen, NSIH-ICU surveillance België, Mertens, 2017 WIV-ISP
22 Blood stream infections (BSI) Figure 10: Variation hospital-associated bloodstream infections between hospitals, Belgium 2017 (HABSI, hospital-associated bloodstream infection; SD, standard deviation) Duysburgh, E. 2018
23 Recoded Pneumonia & Sepsis for the sake of economic benefits
24 Surveillance & notification Outbreak SCIENSANO Reference lab Outbreak support Competent authorities experts Elisabeth Miller & Hélène De Pauw
25
26 Evolution of the consumption* of antibacterials for systemic use (J01) in acute-care Belgian hospitals, RIZIV/INAMI & Healthdata Vandael Eline et al., in prep. Currently 18 months delay realtime monitoring is asked *Expressed in defined daily doses (DDDs)/1000 patient days ( )
27 Anticaterial use (J01) stratified by type of hospitals
28 Stratification BSI by hospital type Duysburgh E. 2018
29 Blood stream infections stratified by region Duysburgh E. 2018
30 Evolution of the consumption* of antibacterials for systemic use (J01) in acute-care Belgian hospitals, RIZIV/INAMI & Healthdata Vandael Eline et al., in prep. *Expressed in defined daily doses (DDDs)/1000 patient days ( )
31 Antibacterial consumption Belgium, 2017 Antibacterials for systemic use (ATC group J01) Consumption of antibacterials for systemic use (ATC group J01) in the community (primary care sector) and the hospital sector expressed in DDD per 1000 inhabitants and per day in 2017 ATC group J01 Community (primary care sector) Hospital sector Beta-lactam antibacterials, penicillins (J01C) Other beta-lactam antibacterials (J01D) Tetracyclines (J01A) Macrolides, lincosamides and streptogramins (J01F) Quinolone antibacterials (J01M) Sulfonamides and trimethoprim (J01E) Other J01 substances Total
32 EARS-net Belgium Mertens, K in press
33 Consumption per animal species (DDD/1000 individual per day) Treatment incidence on UDD (animals/1000 daily treaed) Antimicrobial use in livestock in Belgium poultry pigs dairy cattle beef cattle veal calves Persoons et al., 2012 Callens et al., 2012 Catry et al., 2016 Pardon et al., 2012 Courtesy: B. Pardon, UGent 32
34 BelVetSac.ugent.be
35
36 Results prevalence : Descriptive Statistics Resistance >50% Ampicillin, Tetracycline, Sulphamethoxazole Trimethoprim Resistance strains prevalence Veal calves - E. coli Ampicillin Sulphamethoxazole Resistance (%) Tetracycline Trimethoprim Years
37 Results prevalence : Descriptive Statistics Sulphamethoxazole: 22,50 % (2017) 100 Resistance strains prevalence Beef cattle - E. coli Ampicillin Chloramphenicol 70 Gentamicin Resistance (%) Nalidixic acid Sulphamethoxazole Years Tetracycline Trimethoprim
38 N E. coli = >27 000; 5808; 812 ( )
39
40 Campylobacter jejuni in Poultry Meat (2017) % Sensible stable Co-R to CipNalTet (2 AB families) remains high and stable
41 Salmonella Porcine meat(pri 031) EU-AMR Project EU AMR Autocontrole n 46 EU AMR Gembloux 17 EU AMR Melle 38 Total 101 Famille d AB n % sensible
42 Antimicrobial consumption (J01) per animal species Treatment incidence on UDD (animals/1000 daily treaed) Antimicrobial use in livestock in Belgium poultry pigs dairy cattle beef cattle veal calves Persoons et al., 2012 Callens et al., 2012 Catry et al., 2016 Pardon et al., 2012 Courtesy: B. Pardon, UGent 41
43 Anticaterial use (J01) stratified by type of hospitals Vandael et al, 2018
44 EARS-net Belgium Mertens, K in press
45 Antimicrobial consumption (J01) per animal species Treatment incidence on UDD (animals/1000 daily treaed) Antimicrobial use in livestock in Belgium poultry pigs dairy cattle beef cattle veal calves Persoons et al., 2012 Callens et al., 2012 Catry et al., 2016 Pardon et al., 2012 Courtesy: B. Pardon, UGent 44
46 Antibacterial use Belgium, Intensive care vs hospital wide Vandael et al., 2018
47 Antimicrobial consumption (J01) per animal species Treatment incidence on UDD (animals/1000 daily treaed) Antimicrobial use in livestock in Belgium poultry pigs dairy cattle beef cattle veal calves Persoons et al., 2012 Callens et al., 2012 Catry et al., 2016 Pardon et al., 2012 Courtesy: B. Pardon, UGent 46
48 Antibacterial consumption Belgium, 2017 Antibacterials for systemic use (ATC group J01) Consumption of antibacterials for systemic use (ATC group J01) in the community (primary care sector) and the hospital sector expressed in DDD per 1000 inhabitants and per day in 2017 ATC group J01 Community (primary care sector) Hospital sector Beta-lactam antibacterials, penicillins (J01C) Other beta-lactam antibacterials (J01D) Tetracyclines (J01A) Macrolides, lincosamides and streptogramins (J01F) Quinolone antibacterials (J01M) Sulfonamides and trimethoprim (J01E) Other J01 substances Total ,1 (2016)
49 Concluding remarks Focus on hospital consumption, stratified by type of hospitals Reflection in tertiary hospitals is urgently needed, in particular ICU (e.g. Guidelines vs Systematic reviews) Do no limit focus on acquired multidrug resistance (HAI at large, CDIF, ILI, mycoses, adverse events.) - Hand hygiene campaigns should be further elaborated Requirements: realtime feedback AM consumption = Prerequisite for containment during outbreaks (Outbreak support team) - allows also rapid evaluation of (inter)national intervention strategies One health: direct contact with animals has been underestimated for years Future deliverable: AM & AMR geographical mapping, stratified and open data
50 Acute care hospitals, AB consumption Vandael et al., 2018
51 Acknowledgements: The NSIH team, BAPCOC, NRCs the labs & hospitals & nursing homes & healthcare workers
Summary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union November 2012 Highlights on antibiotic consumption Antibiotic use is one of the main factors responsible for the development and
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite
More informationHow is Ireland performing on antibiotic prescribing?
European Antibiotic Awareness Campaign 2016 November Webinar Series on Antibiotic Prescribing How is Ireland performing on antibiotic prescribing? Dr Rob Cunney National Clinical Lead HCAI AMR Clinical
More informationAMR epidemiological situation: ECDC update
One Health Network on Antimicrobial Resistance (AMR) AMR epidemiological situation: ECDC update Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI)
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationWhat is the problem? Latest data on antibiotic resistance
European Antibiotic Awareness Day 2009 What is the problem? Latest data on antibiotic resistance Zsuzsanna Jakab, ECDC Director Launch Seminar for EAAD Stockholm, 18 November 2009 Fluoroquinolone-resistant
More informationConsultation meeting with stakeholders
Consultation meeting with stakeholders Request from the European Commission for advice on the impact on public and animal health of the use of antibiotics in animals Presented by: Catry Boudewijn CVMP/EMA
More informationSummary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More informationAntibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011
Antibiotic Resistance Antibiotic Resistance: A Growing Concern Judy Ptak RN MSN Infection Prevention Practitioner Dartmouth-Hitchcock Medical Center Lebanon, NH Occurs when a microorganism fails to respond
More informationAntimicrobial resistance and antimicrobial consumption in Europe
Antimicrobial resistance and antimicrobial consumption in Europe Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Programme Vilnius, 28 November
More informationAntimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report
Antimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationInitiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector
Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector Niels Frimodt-Møller Professor, MD DMSc Dept. of Clinical Microbiology Hvidovre Hospital, Copenhagen,
More informationARCH-Vet. Summary 2013
Federal Department of Home Affairs FDHA FSVO ARCH-Vet Report on sales of antibiotics in veterinary medicine and antibiotic resistance monitoring of livestock in Switzerland Summary 2013 Published by Federal
More informationThe epidemiology of antimicrobial resistance and the link between human and veterinary medicine
The epidemiology of antimicrobial resistance and the link between human and veterinary medicine Prof. Dr. Jeroen Dewulf Jeroen.Dewulf@UGent.be Unit for Veterinary Epidemiology, Faculty of Veterinary Medicine
More information03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline
Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More informationANTIMICROBIAL RESISTANCE IN COMMENSAL E. COLI FROM LIVESTOCK IN BELGIUM: Veterinary Epidemiology
ANTIMICROBIAL RESISTANCE IN COMMENSAL E. COLI FROM LIVESTOCK IN BELGIUM: TREND ANALYSIS 2011-2017 Veterinary Epidemiology 03.05.2018 General objectives Monitoring and reporting of antimicrobial resistance
More informationHuman health impacts of antibiotic use in animal agriculture
Human health impacts of antibiotic use in animal agriculture Beliefs, opinions, and evidence Peter Davies BVSc, PhD College of Veterinary Medicine, University of Minnesota, USA Terminology Antibiotic Compound
More informationActivities and achievements related to the reduction in antibiotics use and resistance in veterinary medicine in Belgium in 2016
Activities and achievements related to the reduction in antibiotics use and resistance in veterinary medicine in Belgium in 2016 1 Activities and achievements antibiotics use and resistance among animals
More informationMike Apley Kansas State University
Mike Apley Kansas State University 2003 - Daptomycin cyclic lipopeptides 2000 - Linezolid - oxazolidinones 1985 Imipenem - carbapenems 1978 - Norfloxacin - fluoroquinolones 1970 Cephalexin - cephalosporins
More informationMISSION REPORT. ECDC country visit to Belgium to discuss antimicrobial resistance issues November
MISSION REPORT ECDC country visit to Belgium to discuss antimicrobial resistance issues 20-24 November 2017 www.ecdc.europa.eu ECDC MISSION REPORT ECDC country visit to Belgium to discuss antimicrobial
More informationEuropean Antibiotic Awareness Day
Initiating a pan-european health campaign - experiences from setting up the European Antibiotic Awareness Day Dr Ülla-Karin Nurm Head of Public Health Development Section, Public Health Capacity and Communication
More informationQuelle politique antibiotique pour l Europe? Dominique L. Monnet
Quelle politique antibiotique pour l Europe? Dominique L. Monnet National Center for Antimicrobials & Infection Control Statens Serum Institut, Copenhagen, Denmark Opinion of the Section for Protection
More informationAntibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University
Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine Mike Apley Kansas State University Changes in Food Animal Antibiotic Use How the uses of antibiotics in
More informationECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials
ECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials P.-A. Belœil (EFSA) and D. Monnet (ECDC) One Health Network on Antimicrobial Resistance
More informationHospital ID: 831. Bourguiba Hospital. Tertiary hospital
Global Point Prevalence Survey of Antimicrobial Consumption and Resistance in hospitals worldwide Hospital ID: 831 Habib Bourguiba Hospital Tertiary hospital Tunisia Point Prevalence Survey Habib 2017
More informationPrevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices
Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationNew Drugs for Bad Bugs- Statewide Antibiogram
New Drugs for Bad Bugs- Statewide Antibiogram Felicia Matthews, Pharm.D., BCPS Senior Consultant, Pharmacy Specialty BE MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More informationAntimicrobial use in humans
Antimicrobial use in humans Ann Versporten Prof. Herman Goossens OIE Global Conference on the Responsible and Prudent Use of Antimicrobial Agents for Animals - 13 March 2013 - Ann.versporten@ua.ac.be Herman.goossens@uza.be
More informationImagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening
Multi-Drug Resistant Superbugs- What s the Big Deal? Toni Biasi, RN MSN MPH CIC Infection Prevention Indiana University Health Imagine A World Without Antibiotics A World Where Simple Infections can be
More informationMulti-Drug Resistant Organisms (MDRO)
Multi-Drug Resistant Organisms (MDRO) 2016 What are MDROs? Multi-drug resistant organisms, or MDROs, are bacteria resistant to current antibiotic therapy and therefore difficult to treat. MDROs can cause
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationRecommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland
Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the
More informationEFSA s activities on Antimicrobial resistance in the food chain. Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA
EFSA s activities on Antimicrobial resistance in the food chain Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA EFSA IS The reference body for risk assessment of food and feed in the European Union. Its
More informationAntimicrobial consumption
Antimicrobial consumption Annual Epidemiological Report for 2017 Key facts Twenty-seven countries, comprising 25 EU Member States and two EEA countries (Iceland and Norway) reported data on antimicrobial
More informationTestimony of the Natural Resources Defense Council on Senate Bill 785
Testimony of the Natural Resources Defense Council on Senate Bill 785 Senate Committee on Healthcare March 16, 2017 Position: Support with -1 amendments I thank you for the opportunity to address the senate
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More information1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection
Surveillance, Outbreaks, and Reportable Diseases, Oh My! Assisted Living Facility, Nursing Home and Surveyor Infection Prevention Training February 2015 A.C. Burke, MA, CIC Health Care-Associated Infection
More informationAntimicrobial resistance (EARS-Net)
SURVEILLANCE REPORT Annual Epidemiological Report for 2014 Antimicrobial resistance (EARS-Net) Key facts Over the last four years (2011 to 2014), the percentages of Klebsiella pneumoniae resistant to fluoroquinolones,
More informationEFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication.
EFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication. Dr. Ernesto Liebana BIOHAZ Team Leader European Food Safety Authority (EFSA) EFSA
More information9.4 Antimicrobial Resistance
9.4 Antimicrobial Resistance a) Key Pathogens causing Bloodstream Infections 2016 Summary Estimated 99% coverage of the Irish population versus 97% in 2015 There were 3,057 reports of invasive E. coli
More information9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS
Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS 1 2 Untoward Effects of Antibiotics Antibiotic resistance Adverse drug events (ADEs) Hypersensitivity/allergy Drug side effects
More informationTable 2.01 Overview of Surveillance programs in the Netherlands. available since. GP, laboratories Decentral Hospital,
2 Extensive summary In the Netherlands, several surveillance programs have been developed to monitor antimicrobial resistance in important pathogens in different settings (SERIN, SIRIN, ISIS- AR). In addition,
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationMultidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?
Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Roberta B. Carey, PhD Centers for Disease Control and Prevention Division of Healthcare Quality Promotion Why worry? MDROs Clinical
More informationThe UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England
The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England Chief Medical Officer - Annual Report 2013 Antimicrobial resistance poses catastrophic
More informationStratégie et action européennes
Résistance aux antibiotiques : une impasse thérapeutique? Implications nationales et internationales Stratégie et action européennes Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial
More informationHSE - Health Protection Surveillance Centre Surveillance of Antimicrobial Consumption in Ireland
Surveillance of Antimicrobial Consumption in Ireland Ajay Oza A European Study on the Relationship between Antimicrobial Use and Antimicrobial Resistance (1998-1999) Bronzwaer et al 2002 Emerging Infectious
More informationTaking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms
Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms Nimalie D. Stone, MD,MS Division of Healthcare Quality Promotion National
More informationNorwegian policies to address antimicrobial resistance
Norwegian policies to address antimicrobial resistance Frode Forland, Specialist Director, Division of Infectious Control and Environmental Health, Norwegian Institute of Public Health Karianne Johansen,
More informationHealth Service Executive Parkgate St. Business Centre, Dublin 8 Tel:
Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel: 01 635 2500 www.hse.ie Health Service Executive Oak House, Millennium Park, Naas, Co. Kildare Tel: 045 880 400 www.hse.ie The prevention
More informationPRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse
More informationMRSA control strategies in Europekeeping up with epidemiology?
MRSA 15 years in Belgium MRSA control strategies in Europekeeping up with epidemiology? Marc J. Struelens, MD, PhD Senior Expert, Scientific Advice Unit European Centre for Disease Prevention and Control,
More informationAnimal Antibiotic Use and Public Health
A data table from Nov 2017 Animal Antibiotic Use and Public Health The selected studies below were excerpted from Pew s peer-reviewed 2017 article Antimicrobial Drug Use in Food-Producing Animals and Associated
More informationDR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA The good old days The dread (of) infections that used to rage through the whole communities is muted Their retreat
More informationCollecting and Interpreting Stewardship Data: Breakout Session
Collecting and Interpreting Stewardship Data: Breakout Session Michael S. Calderwood, MD, MPH Regional Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center March 20, 2019 None Disclosures Outline
More informationIntroduction to antimicrobial resistance
Introduction to antimicrobial resistance Philip Howard Consultant Antimicrobial Pharmacist HCAI and AMR Project Lead 4 th March 2015 What is antimicrobial resistance? Antibacterials either kill or stop
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationThe threat of multidrug-resistant microorganisms and how to deal with it in Europe
The threat of multidrug-resistant microorganisms and how to deal with it in Europe Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
More informationECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013
ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013 What is the European Union? 27 Member States 24 official languages
More informationBelgian National Antibiotic Awareness Campaigns
Belgian National Antibiotic Awareness Campaigns Herman Goossens, Stijn De Corte, Samuel Coenen University of Antwerp and BAPCOC Joris Mateusen, Sarah Tulkens Absoluut Belgium Belgian National Antibiotic
More informationInfection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention
Highlights for the Medical Staff Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention Standard Precautions every patient every time a. Hand Hygiene b. Use of Personal Protective Equipment (PPE)
More informationAntimicrobial Stewardship: efective implementation for improved clinical outcomes
The Challenge of MDR and XDR infections; Barcelona September 2018 Antimicrobial Stewardship: efective implementation for improved clinical outcomes José Miguel Cisneros Herreros Infectious Diseases Department
More informationActivities and achievements regarding the reduction in the use of antibiotics and antimicrobial resistance in veterinary medicine in Belgium in 2017
Activities and achievements regarding the reduction in the use of antibiotics and antimicrobial resistance in veterinary medicine in Belgium in 2017 1 Table of contents Context... 2 Summary... 2 Covenant
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationAntibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017
Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,
More informationAntimicrobial Stewardship. Where are we now and where do we need to go?
Safe Patient Care Bugs and Drugs The ongoing challenge of MDROs and AMR 2017 @SPC2016Cork Antimicrobial Stewardship. Where are we now and where do we need to go? Frank O Riordan Antimicrobial pharmacist,
More informationAntimicrobial Resistance Update for Community Health Services
Antimicrobial Resistance Update for Community Health Services Elizabeth Beech Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England October 2015 elizabeth.beech@nhs.net Superbugs
More informationESCMID Online Lecture Library. by author
System for early warning and national surveillance of antimicrobial resistance! Gunnar Kahlmeter Clinical microbiology Växjö, Sweden Early warning for antimicrobial resistance Local level (laboratory uptake
More informationAntimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013
Antimicrobial Resistance Surveillance from sentinel public s, South Africa, 213 Authors: Olga Perovic 1,2, Melony Fortuin-de Smidt 1, and Verushka Chetty 1 1 National Institute for Communicable Diseases
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationWhat bugs are keeping YOU up at night?
What bugs are keeping YOU up at night? Barbara DeBaun, RN, MSN, CIC 26 th Annual Medical Surgical Nursing Conference South San Francisco, CA April 15, 2016 Objectives Describe the top three infectious
More informationNew Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs
New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs Patrick R. Murray, PhD Senior Director, WW Scientific Affairs 2017 BD. BD, the BD Logo and all other trademarks
More informationMISSION REPORT. ECDC country visit to Norway to discuss antimicrobial resistance issues March
MISSION REPORT ECDC country visit to Norway to discuss antimicrobial resistance issues 12-16 March 2018 www.ecdc.europa.eu ECDC MISSION REPORT ECDC country visit to Norway to discuss antimicrobial issues
More informationCampylobacter infections in EU/EEA and related AMR
Campylobacter infections in EU/EEA and related AMR Therese Westrell, ECDC EURL Campylobacter workshop, Uppsala, Sweden, 9 October 2018 Zoonoses Zoonotic infections in the EU, 2016 Campylobacteriosis (N
More informationImplementation of a National Action Plan and International standards especially with regard to Responsible and prudent use of antimicrobials
Implementation of a National Action Plan and International standards especially with regard to Responsible and prudent use of antimicrobials Dr. Sasi Jaroenpoj, D.V.M Head of Veterinary Products and AMR
More informationVaccination as a potential strategy to combat Antimicrobial Resistance in the elderly
Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly Wilbur Chen, MD, MS 22-23 March 2017 WHO meeting on Immunization of the Elderly The Problem Increasing consumption
More informationCountdown to the New Veterinary Feed Directive
Countdown to the New Veterinary Feed Directive Where we are going and what got us here Mike Apley Kansas State University 2003 - Daptomycin cyclic lipopeptides 2000 - Linezolid - oxazolidinones 1985 Imipenem
More informationCANADIAN ANTIMICROBIAL RESISTANCE SURVEILLANCE SYSTEM
CANADIAN ANTIMICROBIAL RESISTANCE SURVEILLANCE SYSTEM UPDATE 2018 PROTECTING AND EMPOWERING CANADIANS TO IMPROVE THEIR HEALTH TO PROMOTE AND PROTECT THE HEALTH OF CANADIANS THROUGH LEADERSHIP, PARTNERSHIP,
More informationNorthwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America
More informationPreventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal
Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal 07.03.01 2009 Methicillin Resistant Staphlococcus aureus (MRSA) About 3-8% of the population at large is a carrier
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More informationGUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 4: Antibiotic Resistance Author M.P. Stevens, MD, MPH S. Mehtar, MD R.P. Wenzel, MD, MSc Chapter Editor Michelle Doll, MD, MPH Topic Outline Key Issues
More information5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)
Multidrug Resistant Organisms (MDROs) Kasturi Shrestha, M.D. 05/11/2018 Objectives Define a multi-drug resistant organism (MDRO) Identify most challenging MDROs in healthcare Identify reasons for health
More informationAntimicrobial consumption
SURVEILLANCE REPORT Annual Epidemiological Report for 2016 Antimicrobial consumption Key facts Twenty-nine countries, including 27 EU Member States and two EEA countries (Iceland and Norway) reported data
More informationAntimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services
Antimicrobial Stewardship/Statewide Antibiogram Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda CMS and JCAHO
More informationAntibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship
Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship J. Hudson Garrett Jr., PhD, MSN, MPH, FNP-BC, PLNC, CDONA, IP-BC, GDCN, CDP, CADDCT, CALN, VA-BC, AS-BC,
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationHealthcare-associated Infections Annual Report December 2018
December 2018 Healthcare-associated Infections Annual Report 2011-2017 TABLE OF CONTENTS INTRODUCTION... 1 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS... 2 MRSA SURVEILLANCE... 3 CLOSTRIDIUM
More informationStratégies et actions au niveau européen et international: populations humaines
Stratégies et actions au niveau européen et international: populations humaines Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More informationAnimal Health and Antibiotics Looking Ahead with Science
Animal Health and Antibiotics Looking Ahead with Science t The Overton Window Unthinkable Radical Acceptable Sensible Popular Policy Prohibition of therapeutic uses of medically important antimicrobials
More informationHalting Infections in Long Term Care
Results of HALT Study 2013 Halting Infections in Long Term Care HALT Seminar Novemeber 2014 DR Nuala O Connor ICGP Lead HCAI AMR DR Bartley Cryan Consultant microbiologist CUH Dr Paul Gallagher Consultant
More informationData for action The Danish approach to surveillance of the use of antimicrobial agents and the occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark 2 nd edition,
More informationESAC s Surveillance by Point Prevalence Measurements. by author
ESAC s Surveillance by Point Prevalence Measurements Herman Goossens, MD, PhD ESAC Co-ordinator VAXINFECTIO, Laboratory of Medical Microbiology University of Antwerp, Belgium Outline Background Point Prevalence
More informationCarbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S
Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S CRE Enterobacteriaceae (Gram Negative Bacilli) Citrobacter species Escherichia coli***
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationANTIBIOTIC RESISTANCE THREATS. in the United States, 2013
ANTIBIOTIC RESISTANCE THREATS in the United States, 2013 TABLE OF CONTENTS Foreword... 5 Executive Summary.... 6 Section 1: The Threat of Antibiotic Resistance... 11 Introduction.... 11 National Summary
More informationTABLE OF CONTENTS Foreword...5 Executive Summary...6 Section 1: The Threat of Antibiotic Resistance...11 Introduction...11 National Summary Data...
TABLE OF CONTENTS Foreword....5 Executive Summary....6 Section 1: The Threat of Antibiotic Resistance....11 Introduction....11 National Summary Data....13 Cycle of Resistance Infographics....14 Minimum
More information